Acute Atherosis of the Uterine Spiral Arteries: Clinicopathologic Implications

키워드

참고문헌 (170)

1. Hertig AT, "Vascular pathology in the hypertensive albuminuric toxemias of pregnancy", Clinics, 4, pp.602~614 (1945)
2. Zeek PM, "Vascular changes in the decidua associated with eclamptogenic toxemia of pregnancy", Am J Clin Pathol, 20, pp.1099~1109 (1950)
3. Hanssens M, "Renin-like immunoreactivity in uterus and placenta from normotensive and hypertensive pregnancies", Eur J Obstet Gynecol Reprod Biol, 81, pp.177~184 (1998)
4. Sexton LI, "Premature separation of the normally implanted placenta; a clinicopathological study of 476 cases", Am J Obstet Gynecol, 59, pp.13~24 (1950)
5. Maqueo M, "Placental pathology in eclampsia and preeclampsia", Obstet Gynecol, 24, pp.350~356 (1964)
6. Driscoll SG, "The pathology of pregnancy complicated by diabetes mellitus", Med Clin N Am, 49, pp.1053~1067 (1965)
7. Robertson WB, "The pathological response of the vessels of the placental bed to hypertensive pregnancy", J Pathol Bacteriol, 93, pp.581~592 (1967)
8. Brosens IA, "The role of the spiral arteries in the pathogenesis of preeclampsia", Obstet Gynecol Annu, 1, pp.177~191 (1972)
9. Brosens I, "On the pathogenesis of placental infarcts in pre-eclampsia", J Obstet Gynaecol Br Commonw, 79, pp.794~799 (1972)
10. Emmrich P, "Morphology of myometrial and de cidual arteries in normal pregnancy, in toxemia of pregnancy, and in maternal diabetes (author’s transl)", Pathol Microbiol (Basel), 43, pp.38~61 (1975)
11. De Wolf F, "The ultrastructure of acute atherosis in hypertensive pregnancy", Am J Obstet Gynecol, 123, pp.164~174 (1975)
12. Robertson WB, "Uteroplacental vascular pathology", Eur J Obstet Gynecol Reprod Biol, 5, pp.47~65 (1975)
13. Robertson WB, "Maternal uterine vascular lesions in the hypertensive complications of pregnancy", Perspect Nephrol Hypertens, 5, pp.115~127 (1976)
14. De Wolf F, "Fetal growth retardation and the maternal arterial supply of the human placenta in the absence of sustained hypertension", Br J Obstet Gynaecol, 87, pp.678~685 (1980)
15. Abramowsky CR, "Decidual vasculopathy of the placenta in lupus erythematosus", N Engl J Med, 303, pp.668~672 (1980)
16. Kitzmiller JL, "Decidual arteriopathy in hypertension and diabetes in pregnancy : immunofluorescent studies", Am J Obstet Gynecol, 141, pp.773~779 (1981)
17. Sheppard BL, "An ultrastructural study of utero-placental spiral arteries in hypertensive and normotensive pregnancy and fetal growth retardation", Br J Obstet Gynaecol, 88, pp.695~705 (1981)
18. De Wolf F, "Decidual vasculopathy and extensive placental infarction in a patient with repeated thromboembolic accidents, recurrent fetal loss, and a lupus anticoagulant", Am J Obstet Gynecol, 142, pp.829~834 (1982)
19. Hustin J, "Maternal vascular lesions in pre-eclampsia and intrauterine growth retardation: light microscopy and immunofluorescence", Placenta, 4, pp.489~498 (1983)
20. Althabe O, "Maternal vascular lesions in placentae of small-for-gestational-age infants", Placenta, 6, pp.265~276 (1985)
21. Labarrere C, "Immunohistochemical findings in acute atherosis associated with intrauterine growth retardation", Am J Reprod Immunol Microbiol, 7, pp.149~155 (1985)
22. Labarrere C, "Chronic villitis of unknown etiology and maternal arterial lesions in preeclamptic pregnancies", Eur J Obstet Gynecol Reprod Biol, 20, pp.1~11 (1985)
23. Khong TY, "Inadequate maternal vascular response to placentation in pregnancies complicated by pre-eclampsia and by small-for-gestational age infants", Br J Obstet Gynaecol, 93, pp.1049~1059 (1986)
24. McFadyen IR, "The relation of birthweight to histological appearances in vessels of the placental bed", Br J Obstet Gynaecol, 93, pp.476~481 (1986)
25. Labarrere CA, "Placental lesions in maternal autoimmune diseases", Am J Reprod Immunol Microbiol, 12, pp.78~86 (1986)
26. Khong TY, "Acute atherosis in preeclampsia : maternal determinants and fetal outcome in the presence of the lesion", Am J Obstet Gynecol, 157, pp.360~363 (1987)
27. Labarrere CA, "Acute atherosis: a histopathological hallmark of immune aggression?", Placenta, 9, pp.95~108 (1988)
28. Frusca T, "Histological features of uteroplacental vessels in normal and hypertensive patients in relation to birthweight", Br J Obstet Gynaecol 1989;, 96, pp.835~839
29. Khong TY, "Acute atherosis in pregnancies complicated by hypertension, small-for-gestational-age infants, and diabetes mellitus", Arch Pathol Lab Med, 115, pp.722~725 (1991)
30. Meekins JW, "A study of placental bed spiral arteries and trophoblast invasion in normal and severe pre-eclamptic pregnancies", Br J Obstet Gynaecol, 101, pp.669~674 (1994)
31. Meekins JW, "Immunohistochemical detection of lipoprotein(a)in the wall of placental bed spiral arteries in normal and severe preeclamptic pregnancies", Placenta, 15, pp.511~524 (1994)
32. Salafia CM, "Placental pathology in systemic lupus erythematosus and phospholipid antibody syndrome", Rheum Dis Clin North Am, 23, pp.85~97 (1997)
33. Brosens I, "Fetal growth retardation and the arteries of the placental bed", Br J Obstet Gynaecol, 84, pp.656~663 (1977)
34. Gerretsen G, "Morphological changes of the spiral arteries in the placental bed in relation to pre-eclampsia and fetal growth retardation", Br J Obstet Gynaecol, 88, pp.876~881 (1981)
35. Nayar R, "Placental changes in a first trimester missed abortion in maternal systemic lupus erythematosus with antiphospholipid syndrome; a case report and review of the literature", Hum Pathol, 27, pp.201~206 (1996)
36. Hayati AR, "Incidence of acute atherosis in complete molar pregnancy", Malays J Pathol, 20, pp.113~114 (1998)
37. Khong TY, "The placenta in maternal hyperhomocysteinaemia", Br J Obstet Gynaecol, 106, pp.273~278 (1999)
38. Ogishima D, "Placental pathology in systemic lupus erythematosus with antiphospholipid antibodies", Pathol Int, 50, pp.224~229 (2000)
39. Sebire NJ, "Extravillus endovascular implantation site trophoblast invasion is abnormal in complete versus partial molar pregnancies", Placenta, 22, pp.725~728 (2001)
40. Moldenhauer JS, "The frequency and severity of placental findings in women with preeclampsia are gestational age dependent", Am J Obstet Gynecol, 189, pp.1173~1177 (2003)
41. Faye-Petersen O, "Handbook of placental pathology", pp.53~78 (2006), Taylor & Francis
42. Harsem NK, "Acute atherosis in decidual tissue : not associated with systemic oxidative stress in preeclampsia", Placenta, 28, pp.958~964 (2007)
43. Fox H, "Pathology of theplacenta", pp.147~186 (2007), Saunders-Elsevier
44. Brosens I, "Placental bed disorders", pp.11~ (2010), Cambridge University Press
45. Staff AC, "Learning from the placenta : acute atherosis and vascular remodeling in preeclampsia-novel aspects for atherosclerosis and future cardiovascular health", Hypertension, 56, pp.1026~1034 (2010)
46. Stevens DU, "Decidual vasculopathy in preeclampsia : lesion characteristics relate to disease severity and perinatal outcome", Placenta, 34, pp.805~809 (2013)
47. Staff AC, "Review: preeclampsia, acute atherosis of the spiral arteries and future cardiovascular disease: two new hypotheses", Placenta, 34(Suppl), pp.S73~S78 (2013)
48. Staff AC, "Preeclampsia and uteroplacental acute atherosis: immune and inflammatory factors", J Reprod Immunol, 101-102, pp.120~126 (2014)
49. Staff AC, "IFPA Award in Placentology Lecture: preeclampsia, the decidual battleground and future maternal cardiovascular disease", Placenta, 35(Suppl), pp.S26~S31 (2014)
50. Mitchell RN, "Graft vascular disease : immune response meets the vessel wall", Annu Rev Pathol, 4, pp.19~47 (2009)
51. Kim YM, "The frequency of acute atherosis in normal pregnancy and preterm labor, preeclampsia, small-for-gestational age, fetal death and midtrimester spontaneous abortion", J Matern Fetal Neonatal Med, 28, pp.2001~2009 (2015)
52. Pijnenborg R, "The uterine spiral arteries in human pregnancy : facts and controversies", Placenta, 27, pp.939~958 (2006)
53. van Rijn BB, "Cardiovascular disease risk factors in women with a history of early-onset preeclampsia", Obstet Gynecol, 121, pp.1040~1048 (2013)
54. Veerbeek JH, "Cardiovascular disease risk factors after early-onset preeclampsia, late-onset preeclampsia, and pregnancy-induced hypertension", Hypertension, 65, pp.600~606 (2015)
55. Sattar N, "Classic and novel risk factor parameters in women with a history of preeclampsia", Hypertension, 42, pp.39~42 (2003)
56. Berends AL, "Shared constitutional risks for maternal vascular-related pregnancy complications and future cardiovascular disease", Hypertension, 51, pp.1034~1041 (2008)
57. van Rijn BB, "C-reactive protein and fibrinogen levels as determinants of recurrent preeclampsia : a prospective cohort study", J Hypertens, 32, pp.408~414 (2014)
58. Brosens I, "The physiological response of the vessels of the placental bed to normal pregnancy", J Pathol Bacteriol, 93, pp.569~579 (1967)
59. Espinoza J, "Normal and abnormal transformation of the spiral arteries during pregnancy", J Perinat Med, 34, pp.447~458 (2006)
60. Freese UE, "The uteroplacental vascular relationship in the human", Am J Obstet Gynecol, 101, pp.8~16 (1968)
61. Brosens IA, "Morphological changes in the utero-placental bed in pregnancy hypertension", Clin Obstet Gynaecol, 4, pp.573~593 (1977)
62. Kim YM, "Failure of physiologic transformation of the spiral arteries in the placental bed in preterm premature rupture of membranes", Am J Obstet Gynecol, 187, pp.1137~1142 (2002)
63. Kim YM, "Failure of physiologic transformation of the spiral arteries in patients with preterm labor and intact membranes", Am J Obstet Gynecol, 189, pp.1063~1069 (2003)
64. Redman CW, "Latest advances in understanding preeclampsia", Science, 308, pp.1592~1594 (2005)
65. Steegers EA, "Pre-eclampsia", Lancet, 376, pp.631~644 (2010)
66. Makris A, "Uteroplacental ischemia results in proteinuric hypertension and elevated sFLT-1", Kidney Int, 71, pp.977~984 (2007)
67. Bujold E, "Evidence supporting that the excess of the sVEGFR-1 concentration in maternal plasma in preeclampsia has a uterine origin", J Matern Fetal Neonatal Med, 18, pp.9~16 (2005)
68. Kusanovic JP, "A prospective cohort study of the value of maternal plasma concentrations of angiogenic and anti-angiogenic factors in early pregnancy and midtrimester in the identification of patients destined to develop preeclampsia", J Matern Fetal Neonatal Med, 22, pp.1021~1038 (2009)
69. Maynard SE, "Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia", J Clin Invest, 111, pp.649~658 (2003)
70. Lain KY, "Contemporary concepts of the pathogenesis and management of preeclampsia", JAMA, 287, pp.3183~3186 (2002)
71. Venkatesha S, "Soluble endoglin contributes to the pathogenesis of preeclampsia", Nat Med, 12, pp.642~649 (2006)
72. Libby P, "Inflammation and atherosclerosis", Circulation, 105, pp.1135~1143 (2002)
73. Libby P, "Inflammation in atherosclerosis", Nature, 420, pp.868~874 (2002)
74. Young JL, "Cytokines in the pathogenesis of atherosclerosis", Thromb Haemost, 88, pp.554~567 (2002)
75. Hansson GK, "The immune response in atherosclerosis : a double-edged sword", Nat Rev Immunol, 6, pp.508~519 (2006)
76. Libby P, "Inflammatory mechanisms: the molecular basis of inflammation and disease", Nutr Rev, 65(12 Pt 2), pp.S140~S146 (2007)
77. Rocha VZ, "Obesity, inflammation, and atherosclerosis", Nat Rev Cardiol, 6, pp.399~409 (2009)
78. Galkina E, "Immune and inflammatory mechanisms of atherosclerosis(*)", Annu Rev Immunol, 27, pp.165~197 (2009)
79. Libby P, "Inflammation in atherosclerosis : transition from theory to practice", Circ J, 74, pp.213~220 (2010)
80. Brosens I, "The"Great Obstetrical Syndromes"are associated with disorders of deep placentation", Am J Obstet Gynecol, 204, pp.193~201 (2011)
81. Kim YM, "Placental lesions associated with acute atherosis", J Matern Fetal Neonatal Med, 28, pp.1554~1562 (2015)
82. Libby P., "Atherosclerosis: disease biology affecting the coronary vasculature", Am J Cardiol, 98, pp.3Q~96Q (2006)
83. Libby P, "Leducq Transatantic Network on Atherothrombosis. Inflammation in atherosclerosis: from pathophysiology to practice", J Am Coll Cardiol, 54, pp.2129~2138 (2009)
84. Packard RR, "Innate and adaptive immunity in atherosclerosis", Semin Immunopathol, 31, pp.5~22 (2009)
85. Andersson J, "Adaptive immunity and atherosclerosis", Clin Immunol, 134, pp.33~46 (2010)
86. Libby P, "Progress and challenges in translating the biology of atherosclerosis", Nature, 473, pp.317~325 (2011)
87. Legein B, "Inflammation and immune system interactions in atherosclerosis", Cell Mol Life Sci, 70, pp.3847~3869 (2013)
88. Libby P, "Immune effector mechanisms implicated in atherosclerosis : from mice to humans", Immunity, 38, pp.1092~1104 (2013)
89. Rosenfeld ME, "Inflammation and atherosclerosis : direct versus indirect mechanisms", Curr Opin Pharmacol, 13, pp.154~160 (2013)
90. Woollard KJ, "Immunological aspects of atherosclerosis", Clin Sci (Lond), 125, pp.221~235 (2013)
91. Ait-Oufella H, "Adaptive(T and B cells)immunity and control by dendritic cells in atherosclerosis", Circ Res, 114, pp.1640~1660 (2014)
92. Kim CJ, "and pathological features of chronic chorioamnionitis : a lesion associated with spontaneous preterm birth", Mod Pathol, 23, pp.1000~1011 (2010)
93. Lee J, "Maternal HLA panel-reactive antibodies in early gestation positively correlate with chronic chorioamnionitis : evidence in support of the chronic nature of maternal anti-fetal rejection", Am J Reprod Immunol, 66, pp.510~526 (2011)
94. Lee J, "A signature of maternal anti-fetal rejection in spontaneous preterm birth: chronic chorioamnionitis, anti-human leukocyte antigen antibodies, and C4d", PLoS One, 6, pp.e16806~ (2011)
95. Lee J, "Chronic chorioamnionitis is the most common placental lesion in late preterm birth", Placenta, 34, pp.681~689 (2013)
96. Mach F, "Differential expression of three T lymphocyte-activating CXC chemokines by human atheroma-associated cells", J Clin Invest, 104, pp.1041~1050 (1999)
97. Pijnenborg R, "Immunolocalization of tumour necrosis factor-alpha(TNF-alpha)in the placental bed of normotensive and hypertensive human pregnancies", Placenta, 19, pp.231~239 (1998)
98. Sacks GP, "Normal pregnancy and preeclampsia both produce inflammatory changes in peripheral blood leukocytes akin to those of sepsis", Am J Obstet Gynecol, 179, pp.80~86 (1998)
99. Naccasha N, "Phenotypic and metabolic characteristics of monocytes and granulocytes in normal pregnancy and maternal infection", Am J Obstet Gynecol, 185, pp.1118~1123 (2001)
100. Brenner B, "Haemostatic changes in pregnancy", Thromb Res, 114, pp.409~414 (2004)
101. Watts DH, "C-reactive protein in normal pregnancy", Obstet Gynecol, 77, pp.176~180 (1991)
102. Gervasi MT, "Phenotypic and metabolic characteristics of maternal monocytes and granulocytes in preterm labor with intact membranes", Am J Obstet Gynecol, 185, pp.1124~1129 (2001)
103. Pitiphat W, "Plasma C-reactive protein in early pregnancy and preterm delivery", Am J Epidemiol, 162, pp.1108~1113 (2005)
104. Gotsch F, "The anti-inflammatory limb of the immune response in preterm labor, intra-amniotic infection", inflammation, and spontaneous parturition at term: a role for interleukin-10, 2008, pp.21, 529~547
105. Kim MA, "Serum markers for prediction of spontaneous preterm delivery in preterm labour", Eur J Clin Invest, 41, pp.773~780 (2011)
106. Laudanski P, "Assessment of the selected biochemical markers in predicting preterm labour", J Matern Fetal Neonatal Med, 25, pp.2696~2699 (2012)
107. Cruciani L, "Pentraxin 3 in maternal circulation: an association with preterm labor and preterm PROM, but not with intra-amniotic infection", inflammation, 2010, pp.23, 1097~1105
108. Stampalija T, "Soluble ST2, a modulator of the inflammatory response, in preterm and term labor", J Matern Fetal Neonatal Med, 27, pp.111~121 (2014)
109. Ismail MA, "The significance of C-reactive protein levels in women with premature rupture of membranes", Am J Obstet Gynecol, 151, pp.541~544 (1985)
110. Yoon BH, "Serum C-reactive protein, white blood cell count, and amniotic fluid white blood cell count in women with preterm premature rupture of membranes", Obstet Gynecol, 88, pp.1034~1040 (1996)
111. Gervasi MT, "Maternal intravascular inflammation in preterm premature rupture of membranes", J Matern Fetal Neonatal Med, 11, pp.171~175 (2002)
112. Loukovaara MJ, "Serum highly sensitive C-reactive protein in preterm premature rupture of membranes", Eur J Obstet Gynecol Reprod Biol, 110, pp.26~28 (2003)
113. Moghaddam Banaem L, "Maternal serum C-reactive protein in early pregnancy and occurrence of preterm premature rupture of membranes and preterm birth", J Obstet Gynaecol Res, 38, pp.780~786 (2012)
114. Gulati S, "Maternal serum interleukin-6 and its association with clinicopathological infectious morbidity in preterm premature rupture of membranes : a prospective cohort study", J Matern Fetal Neonatal Med, 25, pp.1428~1432 (2012)
115. Vince GS, "Interleukin-6, tumour necrosis factor and soluble tumour necrosis factor receptors in women with pre-eclampsia", Br J Obstet Gynaecol, 102, pp.20~25 (1995)
116. Hamai Y, "Evidence for an elevation in serum interleukin-2 and tumor necrosis factor-alpha levels before the clinical manifestations of preeclampsia", Am J Reprod Immunol, 38, pp.89~93 (1997)
117. Conrad KP, "Circulating levels of immunoreactive cytokines in women with preeclampsia", Am J Reprod Immunol, 40, pp.102~111 (1998)
118. Redman CW, "Preeclampsia: an excessive maternal inflammatory response to pregnancy", Am J Obstet Gynecol, 180(2 Pt 1), pp.499~506 (1999)
119. Sabatier F, "Neutrophil activation in preeclampsia and isolated intrauterine growth restriction", Am J Obstet Gynecol, 183, pp.1558~1563 (2000)
120. Gervasi MT, "Phenotypic and metabolic characteristics of monocytes and granulocytes in preeclampsia", Am J Obstet Gynecol, 185, pp.792~797 (2001)
121. Teran E, "Elevated C-reactive protein and pro-inflammatory cytokines in Andean women with pre-eclampsia", Int J Gynaecol Obstet, 75, pp.243~249 (2001)
122. Chaiworapongsa T, "Soluble adhesion molecule profile in normal pregnancy and pre-eclampsia", J Matern Fetal Neonatal Med, 12, pp.19~27 (2002)
123. Chaiworapongsa T, "Maternal lymphocyte subpopulations(CD45RA+ and CD45RO+)in preeclampsia", Am J Obstet Gynecol, 187, pp.889~893 (2002)
124. Velzing-Aarts FV, "High serum interleukin-8 levels in afro-caribbean women with pre-eclampsia: relations with tumor necrosis factor-alpha, duffy negative phenotype and von Willebrand factor", Am J Reprod Immunol, 48, pp.319~322 (2002)
125. Serin IS, "Predictive value of tumor necrosis factor alpha (TNF-alpha) in preeclampsia", Eur J Obstet Gynecol Reprod Biol, 100, pp.143~145 (2002)
126. Belo L, "Neutrophil activation and C-reactive protein concentration in preeclampsia", Hypertens Pregnancy, 22, pp.129~141 (2003)
127. Levine RJ, "Two-stage elevation of cell-free fetal DNA in maternal sera before onset of preeclampsia", Am J Obstet Gynecol, 190, pp.707~713 (2004)
128. Kocyigit Y, "cytokines and lipoprotein in pre-eclamptic and normotensive pregnant women", Gynecol Endocrinol, 19, pp.267~273 (2004)
129. Freeman DJ, "Short-and long-term changes in plasma inflammatory markers associated with preeclampsia", Hypertension, 44, pp.708~714 (2004)
130. Kim YM, "Toll-like receptor 4: a potential link between “danger signals,” the innate immune system, and preeclampsia?", Am J Obstet Gynecol, 193(3 Pt 2), pp.921~927 (2005)
131. Braekke K, "Calprotectin, a marker of inflammation, is elevated in the maternal but not in the fetal circulation in preeclampsia", Am J Obstet Gynecol, 193, pp.227~233 (2005)
132. Enquobahrie DA, "Maternal plasma transforming growth factor-beta1 concentrations in preeclamptic and normotensive pregnant Zimbabwean women", J Matern Fetal Neonatal Med, 17, pp.343~348 (2005)
133. Jonsson Y, "Cytokine mapping of sera from women with preeclampsia and normal pregnancies", J Reprod Immunol, 70, pp.83~91 (2006)
134. Kusanovic JP, "but decreased in preeclampsia and small for gestational age pregnancies", J Matern Fetal Neonatal Med, 20, pp.867~878 (2007)
135. Sharma A, "Leptin, IL-10 and inflammatory markers (TNF-alpha, IL-6 and IL-8) in pre-eclamptic, normotensive pregnant and healthy non-pregnant women", Am J Reprod Immunol, 58, pp.21~30 (2007)
136. Laskowska M, "Comparative analysis of the maternal and umbilical interleukin-8 levels in normal pregnancies and in pregnancies complicated by preeclampsia with intrauterine normal growth and intrauterine growth retardation", J Matern Fetal Neonatal Med, 20, pp.527~532 (2007)
137. Sibai B, "Maternal plasma concentrations of the soluble tumor necrosis factor receptor 2 are increased prior to the diagnosis of preeclampsia", Am J Obstet Gynecol, 200, pp.630.e1~630.e8 (2009)
138. Ogge G, "Leukocytes of pregnant women with small-for-gestational age neonates have a different phenotypic and metabolic activity from those of women with preeclampsia", J Matern Fetal Neonatal Med, 23, pp.476~487 (2010)
139. Soto E, "Preeclampsia and pregnancies with small-for-gestational age neonates have different profiles of complement split products", J Matern Fetal Neonatal Med, 23, pp.646~657 (2010)
140. Szarka A, "Circulating cytokines, chemokines and adhesion molecules in normal pregnancy and preeclampsia determined by multiplex suspension array", BMC Immunol, 11, pp.59~ (2010)
141. Xie C, "A meta-analysis of tumor necrosis factor-alpha, interleukin-6, and interleukin-10 in preeclampsia", Cytokine, 56, pp.550~559 (2011)
142. Twina G, "Lower circulation levels and activity of alpha-1 antitrypsin in pregnant women with severe preeclampsia", J Matern Fetal Neonatal Med, 25, pp.2667~2670 (2012)
143. Stampalija T, "Maternal plasma concentrations of sST2 and angiogenic", anti-angiogenic factors in preeclampsia, 2013, pp.26, 1359~1370
144. Sahin S, "The impact of platelet functions and inflammatory status on the severity of preeclampsia", J Matern Fetal Neonatal Med, 28, pp.643~648 (2015)
145. Labarrere C, "Intrauterine growth retardation of unknown etiology. I. Serum complement and circulating immune complexes in mothers and infants", Am J Reprod Immunol Microbiol, 8, pp.87~93 (1985)
146. Labarrere CA, "Intrauterine growth retardation of unknown etiology: II. Serum complement and circulating immune complexes in maternal sera and their relationship with parity and chronic villitis", Am J Reprod Immunol Microbiol, 12, pp.4~6 (1986)
147. Johnston TA, "Neutrophil activation in small for gestational age pregnancies", Br J Obstet Gynaecol, 98, pp.105~106 (1991)
148. Johnson MR, "Does endothelial cell activation occur with intrauterine growth restriction?", BJOG, 109, pp.836~839 (2002)
149. Coata G, "Soluble adhesion molecules: marker of pre-eclampsia and intrauterine growth restriction", J Matern Fetal Neonatal Med, 12, pp.28~34 (2002)
150. Tjoa ML, "Elevated C-reactive protein levels during first trimester of pregnancy are indicative of preeclampsia and intrauterine growth restriction", J Reprod Immunol, 59, pp.29~37 (2003)
151. Cetin I, "Elevated maternal levels of the long pentraxin 3(PTX3)in preeclampsia and intrauterine growth restriction", Am J Obstet Gynecol, 194, pp.1347~1353 (2006)
152. Girardi G, "Complement activation induces dysregulation of angiogenic factors and causes fetal rejection and growth restriction", J Exp Med, 203, pp.2165~2175 (2006)
153. Laskowska M, "Maternal and umbilical sTNF-R1 in preeclamptic pregnancies with intrauterine normal and growth retarded fetus", Hypertens Pregnancy, 26, pp.13~21 (2007)
154. Erez O, "Tissue factor and its natural inhibitor in pre-eclampsia and SGA", J Matern Fetal Neonatal Med, 21, pp.855~869 (2008)
155. Duff P, "Pyelonephritis in pregnancy", Clin Obstet Gynecol, 27, pp.17~31 (1984)
156. Gilstrap LC, "Urinary tract infections in women", Curr Opin Obstet Gynecol, 2, pp.643~648 (1990)
157. Soto E, "Increased concentration of the complement split product C5a in acute pyelonephritis during pregnancy", J Matern Fetal Neonatal Med, 17, pp.247~252 (2005)
158. Rajamäki K, "Cholesterol crystals activate the NLRP3 inflammasome in human macrophages: a novel link between cholesterol metabolism and inflammation", PLoS One, 5, pp.e11765~ (2010)
159. Small DM, "Physical-chemical basis of lipid deposition in atherosclerosis", Science, 185, pp.222~229 (1974)
160. Sattar N, "Lipoprotein subfraction concentrations in preeclampsia : pathogenic parallels to atherosclerosis", Obstet Gynecol, 89, pp.403~408 (1997)
161. Lorentzen B, "Sera from preeclamptic women increase the content of triglycerides and reduce the release of prostacyclin in cultured endothelial cells", Thromb Res, 63, pp.363~372 (1991)
162. Hubel CA, "Fasting serum triglycerides, free fatty acids, and malondialdehyde are increased in preeclampsia, are positively correlated, and decrease within 48 hours post partum", Am J Obstet Gynecol, 174, pp.975~982 (1996)
163. Belo L, "Similarities between pre-eclampsia and atherosclerosis: a protective effect of physical exercise?", Curr Med Chem, 15, pp.2223~2229 (2008)
164. Lau SY, "Tumor necrosis factor-alpha, interleukin-6, and interleukin-10 levels are altered in preeclampsia: a systematic review and meta-analysis", Am J Reprod Immunol, 70, pp.412~427 (2013)
165. Chaiworapongsa T, "Pre-eclampsia part 1: current understanding of its pathophysiology", Nat Rev Nephrol, 10, pp.466~480 (2014)
166. Boyd EM, "The lipemia of pregnancy", J Clin Invest, 13, pp.347~363 (1934)
167. Potter JM, "The hyperlipidemia of pregnancy in normal and complicated pregnancies", Am J Obstet Gynecol, 133, pp.165~170 (1979)
168. Baker AM, "Maternal serum dyslipidemia occurs early in pregnancy in women with mild but not severe preeclampsia", Am J Obstet Gynecol, 201, pp.293.e1~293.e4 (2009)
169. 169. Labarrere CA, "Antigenic identification of cells in spiral artery trophoblastic invasion: validation of histologic studies by triple-antibody immunocytochemistry", Am J Obstet Gynecol, 171, pp.165~171 (1994)
170. Roberts JM, "Pre-eclampsia : more than pregnancy-induced hypertension", Lancet, 341, pp.1447~1451 (1993)